People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Fox Foundation, found that an overwhelming 84% of patients with Parkinson's disease report struggling with sleep issues. These were strongly linked to increased symptoms of depression, greater ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results